1. Cell Cycle/DNA Damage Apoptosis
  2. p97 Apoptosis
  3. Eeyarestatin I

Eeyarestatin I  (Synonyms: イヤレスタチンI)

製品番号: HY-110078 純度: 99.56%
COA 取扱説明書 Technical Support

Eeyarestatin I, a potent endoplasmic reticulum-associated protein degradation (ERAD) inhibitor, is a potent protein translocation inhibitor. Eeyarestatin I inhibits Sec61 translocon. Eeyarestatin I targets the p97-associated deubiquitinating process (PAD) and inhibits atx3-dependent deubiquitination. Eeyarestatin I interferes at a step prior to proteasomal degradation. Eeyarestatin I induces cell death via the proapoptotic protein NOXA and has anticancer effects.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 412960-54-4

容量 価格(税別) 在庫状況 数量
>無料サンプル (0.1 - 0.2 mg)   今すぐ申し込む  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 250 在庫あり
Solution
10 mM * 1 mL in DMSO USD 250 在庫あり
Solid
5 mg $180 在庫あり
10 mg $300 在庫あり
50 mg   お問い合わせ  
100 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 11 publication(s) in Google Scholar

Top Publications Citing Use of Products

    Eeyarestatin I purchased from MedChemExpress. Usage Cited in: Oncogene. 2025 Oct;44(39):3713-3728.  [Abstract]

    The shEMC2 MDA-MB-231 and BT-20 cells were treated with the ERAD pathway inhibitor Eeyarestatin I (Eer I) (10 μM) for the indicated time (8-16 h) for the western blot detection of FDFT1 and EMC2 expression, n = 3. The results showed that Eeyarestatin I (Eer I) significantly reversed the downregulation of FDFT1 induced by EMC2.

    Eeyarestatin I purchased from MedChemExpress. Usage Cited in: J Hazard Mater. 2024 Jul 5:472:134466.  [Abstract]

    Eeyarestatin I (Eer1, 5 μM; 6 h) alleviated CdCl₂-induced SigmaR1 degradation in SH-SY5Y cells treated with CdCl₂ (1 μM; 72 h) by inhibiting ERAD. Eeyarestatin I (Eer1, 5 μM; 6 h) also reversed the activation of the p53/p21/Rb pathway.

    Eeyarestatin I purchased from MedChemExpress. Usage Cited in: J Hazard Mater. 2024 Jul 5:472:134466.  [Abstract]

    Eeyarestatin I (Eer1, 5 μM; 6 h) reduced IL‑6 levels in CdCl₂‑treated SH‑SYY5Y cells.

    Eeyarestatin I purchased from MedChemExpress. Usage Cited in: J Hazard Mater. 2024 Jul 5:472:134466.  [Abstract]

    Eeyarestatin I (Eer1, 5 μM; 6 h) reduced the number of senescent cells in CdCl₂‑treated SH‑SY5Y cells.

    Eeyarestatin I purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2023 Sep 15;124(Pt A):110905.  [Abstract]

    After pretreatment with Eeyarestatin I (Eer I, 2 μM) for 2 h, cells were exposed to BON (2 μM) for 8 h, and the protein levels were measured. The results showed that Eeyarestatin I (Eer I) markedly suppressed the reduction in PD-L1 protein levels following BON or MET exposure.
    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Eeyarestatin I, a potent endoplasmic reticulum-associated protein degradation (ERAD) inhibitor, is a potent protein translocation inhibitor. Eeyarestatin I inhibits Sec61 translocon. Eeyarestatin I targets the p97-associated deubiquitinating process (PAD) and inhibits atx3-dependent deubiquitination. Eeyarestatin I interferes at a step prior to proteasomal degradation. Eeyarestatin I induces cell death via the proapoptotic protein NOXA and has anticancer effects[1][2][3][4][5].

    IC50 & Target

    Endoplasmic reticulum-associated protein degradation (ERAD)[1][2]

    Cellular Effect
    Cell Line Type Value Description References
    JeKo-1 IC50
    4 3
    Compound: Eeyarestatin 1
    Growth inhibition of human JeKo1 cells assessed as reduction in cell viability by MTT assay
    Growth inhibition of human JeKo1 cells assessed as reduction in cell viability by MTT assay
    [PMID: 31550150]
    JeKo-1 IC50
    4 3
    Compound: Eeyarestatin 1
    Growth inhibition of human JeKo1 cells assessed as reduction in cell viability by MTT assay
    Growth inhibition of human JeKo1 cells assessed as reduction in cell viability by MTT assay
    [PMID: 31550150]
    MIA PaCa-2 EC50
    4.1 3
    Compound: 21
    Antiproliferative activity against human MIA PaCa-2 cells
    Antiproliferative activity against human MIA PaCa-2 cells
    [PMID: 35033884]
    MIA PaCa-2 EC50
    4.1 3
    Compound: 21
    Antiproliferative activity against human MIA PaCa-2 cells
    Antiproliferative activity against human MIA PaCa-2 cells
    [PMID: 35033884]
    体外実験

    Eeyarestatin I (2.5-40 μM; 48 hours; A549 and H358 cells) treatment causes a dose-dependent cell death of both A549 and H358 cells[1].
    Eeyarestatin I (2.5-40 μM; 48 hours; A549 and H358 cells) treatment increases endoplasmic reticulum (ER) stress markers including Bip and CHOP as low as 20 μM. Eeyarestatin I treatment shows a dose dependent ubiquitination of key proteins including PERK and IRE1α[1].
    Eeyarestatin I (20 μM; 48 hours; A549 and H358 cells) treatment induces cell migration and cell invasion[1].
    Eeyarestatin 1 prevents the transfer of nascent proteins from the membrane-targeting complex to the ER translocation machinery, most probably by inactivating the Sec61 complex[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Viability Assay[1]

    Cell Line: A549 and H358 cells
    Concentration: 2.5 μM, 5 μM, 10 μM, 20 μM, 40 μM
    Incubation Time: 48 hours
    Result: Caused dose dependent cell death of both A549 and H358 cells.

    Western Blot Analysis[1]

    Cell Line: A549 and H358 cells
    Concentration: 2.5 μM, 5 μM, 10 μM, 20 μM, 40 μM
    Incubation Time: 48 hours
    Result: Increased ER stress markers including Bip and CHOP.
    分子量

    630.44

    分子式

    C27H25Cl2N7O7

    CAS 番号
    Appearance

    Solid

    Color

    Yellow to orange

    SMILES

    ON(C(C1(C)C)N(C(C=C2)=CC=C2Cl)C(N1CC(N/N=C/C=C/C(O3)=CC=C3[N+]([O-])=O)=O)=O)C(NC(C=C4)=CC=C4Cl)=O

    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件

    -20°C, sealed storage, away from moisture

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    溶剤 & 溶解度
    体外: 

    DMSO : 25 mg/mL (39.65 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.5862 mL 7.9310 mL 15.8619 mL
    5 mM 0.3172 mL 1.5862 mL 3.1724 mL
    10 mM 0.1586 mL 0.7931 mL 1.5862 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: 1.25 mg/mL (1.98 mM); Suspended solution; Need ultrasonic

      This protocol yields a suspended solution of 1.25 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    純度とドキュメンテーション

    純度: 99.56%

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 1.5862 mL 7.9310 mL 15.8619 mL 39.6548 mL
    5 mM 0.3172 mL 1.5862 mL 3.1724 mL 7.9310 mL
    10 mM 0.1586 mL 0.7931 mL 1.5862 mL 3.9655 mL
    15 mM 0.1057 mL 0.5287 mL 1.0575 mL 2.6437 mL
    20 mM 0.0793 mL 0.3965 mL 0.7931 mL 1.9827 mL
    25 mM 0.0634 mL 0.3172 mL 0.6345 mL 1.5862 mL
    30 mM 0.0529 mL 0.2644 mL 0.5287 mL 1.3218 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Eeyarestatin I
    製品番号:
    HY-110078
    数量:
    MCE 日本正規代理店: